Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib.
Pinter M, Sieghart W, Hucke F, Graziadei I, Vogel W, Maieron A, Königsberg R, Weissmann A, Kornek G, Matejka J, Stauber R, Buder R, Grünberger B, Schöniger-Hekele M, Müller C, Peck-Radosavljevic M.
Pinter M, et al. Among authors: grunberger b.
Aliment Pharmacol Ther. 2011 Oct;34(8):949-59. doi: 10.1111/j.1365-2036.2011.04823.x. Epub 2011 Aug 24.
Aliment Pharmacol Ther. 2011.
PMID: 21883324
Free article.